Allopurinol Tablet
Product Images NDC 67544-313

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 67544-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 300 mg (67544 0313 45)

Bottle Label 300 mg (67544 0313 45)
Allopurinol 300 mg tablets label showing 45 tablets per container. The label includes storage instructions to keep between 20-25 degrees Celsius and dispense in a tight light-resistant container. It indicates manufacturing by Watson Pharma Private Limited, India, and packaging by Aphena Pharma, Cookeville, TN. The NDC number is 67544-0313-45, and the product is for prescription use only.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Allopurinol Structural Formula (Image 1)

Allopurinol Structural Formula (Image 1)
Chemical structure diagram of allopurinol showing its molecular framework including nitrogen atoms and a ketone group.*
FDA Label Image

Allopurinol Is A Structural Analogue Of The Natural Purine Base, Hypoxanthine. It Is An Inhibitor Of Xanthine Oxidase, The Enzyme Responsible For The Conversion Of Hypoxanthine To Xanthine And Of Xanthine To Uric Acid, The End Product Of Purine Metabolism In Man. Allopurinol Is Metabolized To The Corresponding Xanthine Analogue, Oxipurinol (alloxanthine), Which Also Is An Inhibitor Of Xanthine Oxidase. (Image 2)

Allopurinol Is A Structural Analogue Of The Natural Purine Base, Hypoxanthine. It Is An Inhibitor Of Xanthine Oxidase, The Enzyme Responsible For The Conversion Of Hypoxanthine To Xanthine And Of Xanthine To Uric Acid, The End Product Of Purine Metabolism In Man. Allopurinol Is Metabolized To The Corresponding Xanthine Analogue, Oxipurinol (alloxanthine), Which Also Is An Inhibitor Of Xanthine Oxidase. (Image 2)
Chemical structure diagram showing Allopurinol and related compounds including Oxipurinol, Hypoxanthine, Xanthine, and Uric Acid with hydrogen and nitrogen atoms labeled and arrows indicating chemical transformations between these molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.